Koāte-DVI Indications & Usage

  • Koāte-DVI is indicated for the treatment of classical hemophilia (hemophilia A) in which there is a demonstrated deficiency of activity of the plasma-clotting factor, factor VIII1
  • Koāte-DVI, a plasma-derived factor VIII concentrate, contains naturally occurring von Willebrand factor, which is co-purified as part of the manufacturing process1
  • Koāte-DVI has not been investigated for efficacy in the treatment of von Willebrand disease, and is not approved for such usage1
                                                                Koate vial
Reference: 1. Koate-DVI [prescribing information]. Fort Lee, NJ: Kedrion Biopharma Inc., 2012.